New scan could spot hidden cancer left behind after liver surgery

NCT ID NCT07704216

Not yet recruiting Knowledge-focused Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study investigates whether a special 3D MRI scan, called magnetic resonance elastography (3D-MRE), can detect microscopic tumor remnants at the surgical margin after liver cancer removal. Current methods only examine the removed tissue, not the remaining liver. Researchers will compare scan results with standard pathology and track patients for recurrence. If accurate, this non-invasive approach could improve post-surgery monitoring and help guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Three-Dimensional Magnetic Resonance Elastography (3D-MRE) imaging scan
What this could lead to: If successful, this scan could help doctors identify patients at high risk of cancer returning after liver surgery, allowing for earlier intervention.
What could go wrong: This is an early-stage observational study with 150 participants, so results may not apply to all liver cancer patients. The scan's accuracy may be limited, and it is not a treatment itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER LIVER METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma hepatocellular carcinoma intrahepatic cholangiocarcinoma metastasis from malignant tumor of colon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATO CELLULAR CARCINOMA INTRAHEPATIC BILE DUCT CARCINOMA METASTATIC HEPATOCELLULAR CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.